Analyst Ratings for Sage Therapeutics (SAGE)
SAGE Rating Summary
SAGE Price Target Summary
- Highest: $12.00 (H.C. Wainwright)
- Lowest: $8.50 (Canaccord)
- Average: $9.08
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$9.08 (+4.6%)
* Over Last 12-Mos
Rating Score: 1 / 10
Percentile Rank: 9%
Avg. $ Target:
$9.08 (+4.6%)
* Over Last 12-Mos
Rating Score: 1 / 10
Percentile Rank: 9%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2025 | Scotiabank | George Farmer | Downgrade | Sector Perform (Sector Outperform) |
9.20 (12.00) |
9.20 (8.68) |
-5.65% | Details |
| 6/17/2025 | Piper Sandler | David Amsellem | Downgrade | Neutral (Overweight) |
8.50 (9.00) |
6.70 (8.68) |
29.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
